Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®)

Clinical trial NCT03457311 · UNKNOWN

Trial details

NCT number: NCT03457311
Sponsor: Richever Enterprise Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Galactose Single Point (GSP), Residual Liver Function

Start date: 2013-09-09
Primary completion: 2018-03-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.